HK1078646A1 - Materials and methods for examining and treating nasopharyngeal carcinoma - Google Patents

Materials and methods for examining and treating nasopharyngeal carcinoma

Info

Publication number
HK1078646A1
HK1078646A1 HK05110342A HK05110342A HK1078646A1 HK 1078646 A1 HK1078646 A1 HK 1078646A1 HK 05110342 A HK05110342 A HK 05110342A HK 05110342 A HK05110342 A HK 05110342A HK 1078646 A1 HK1078646 A1 HK 1078646A1
Authority
HK
Hong Kong
Prior art keywords
examining
materials
methods
nasopharyngeal carcinoma
treating nasopharyngeal
Prior art date
Application number
HK05110342A
Other languages
English (en)
Inventor
Aylwin Ng
Jing Tang
Kam Hui
Christopher Goh
Original Assignee
Kam Man Hui
Christopher Goh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kam Man Hui, Christopher Goh filed Critical Kam Man Hui
Publication of HK1078646A1 publication Critical patent/HK1078646A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
HK05110342A 2002-01-23 2005-11-18 Materials and methods for examining and treating nasopharyngeal carcinoma HK1078646A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0201498.3A GB0201498D0 (en) 2002-01-23 2002-01-23 Materials and methods for treating cancer
PCT/GB2003/000329 WO2003062826A2 (en) 2002-01-23 2003-01-23 Materials and methods for examining and treating nasopharyngeal carcinoma

Publications (1)

Publication Number Publication Date
HK1078646A1 true HK1078646A1 (en) 2006-03-17

Family

ID=9929586

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05110342A HK1078646A1 (en) 2002-01-23 2005-11-18 Materials and methods for examining and treating nasopharyngeal carcinoma

Country Status (5)

Country Link
US (1) US20060127896A1 (xx)
CN (1) CN1325918C (xx)
GB (1) GB0201498D0 (xx)
HK (1) HK1078646A1 (xx)
WO (1) WO2003062826A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2439225T3 (es) 2004-01-26 2014-01-22 President And Fellows Of Harvard College Sistema y método para el suministro de fluidos
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
BRPI0616139A2 (pt) * 2005-09-22 2011-06-07 China Synthetic Rubber Corp método para avaliar o risco de metástase à distáncia, microestrutura de ácido nucléico útil na determinação do risco de metástase à distáncia e coleção em meio ou kit
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
CN101104852A (zh) * 2006-07-10 2008-01-16 中山大学肿瘤防治中心 与鼻咽癌相关的人类新基因loc344967及其编码的蛋白产物
KR102004559B1 (ko) 2011-08-30 2019-07-26 아스텍스 파마수티컬스, 인크. 데시타빈 유도체 제제
ES2741001T3 (es) 2013-03-13 2020-02-07 Opko Diagnostics Llc Mezcla de fluidos en sistemas fluídicos
KR102587637B1 (ko) 2014-12-12 2023-10-10 옵코 다이어그노스틱스, 엘엘씨 성형에 의해 제조되는 유체 시스템을 비롯한, 항온 처리 채널을 포함하는 유체 시스템
JP6768722B2 (ja) 2015-07-02 2020-10-14 大塚製薬株式会社 凍結乾燥医薬組成物
BR112020002280A2 (pt) 2017-08-03 2020-07-28 Otsuka Pharmaceutical Co., Ltd. composto farmacológico e métodos purificação do mesmo
TWI680297B (zh) * 2018-07-04 2019-12-21 長庚大學 評估罹癌個體是否適用抗癌藥物的方法
CN113559094A (zh) * 2021-08-25 2021-10-29 西北农林科技大学 一种抗坏血酸钠的应用

Also Published As

Publication number Publication date
WO2003062826A2 (en) 2003-07-31
CN1325918C (zh) 2007-07-11
WO2003062826A3 (en) 2003-10-16
CN1643377A (zh) 2005-07-20
US20060127896A1 (en) 2006-06-15
GB0201498D0 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
HK1078646A1 (en) Materials and methods for examining and treating nasopharyngeal carcinoma
EP1484366A4 (en) TREATED PIGMENT, USE AND COMPOUND FOR THE TREATMENT OF PIGMENTS
AU2003269979A8 (en) Process for enhancing material properties and materials so enhanced
AU2003291736A8 (en) Methods and materials for examining pathways associated with glioblastoma progression
IL164352A0 (en) Methods for treating tweak-related conditions
EP1575495A4 (en) COMPOUNDS AND METHODS
EP1468118A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP1567198A4 (en) MATERIALS AND METHOD FOR THE TREATMENT OF EYE DISEASES
IL164219A0 (en) Method for treating and preventing hyparathyroidism
AU2003268032A8 (en) Composition and methods for treatment and screening
EP1593729A4 (en) MATERIAL FOR TREATING A HARMFUL SUBSTANCE AND METHOD FOR TREATING HARMFUL SUBSTANCE USING SAID MATERIAL
IL163835A0 (en) Method for treating carbonaceous materials
GB0201015D0 (en) Hydrocarbon treating
GB0319737D0 (en) Pet-flaps and apparatus for use therewith
AU2003298708A8 (en) Gpc99 and gpc99a: methods and compositions for treating cancer
AU2003209265A8 (en) Mrp9 and its use detecting and treating cancer
GB0223325D0 (en) Treating cancer
IL163878A0 (en) Compositions and methods for treating mdma-inducedtoxicity
IL166025A0 (en) Combination therapy and means for carrying out said therapy
AU2003288014A1 (en) Method and device for treating fibrous material
AU2003295604A8 (en) Gpc15: methods and compositions for treating cancer
AU2003223357A8 (en) Compounds and methods
AUPS265002A0 (en) Water treatment and particulate material for use therein
GB0306425D0 (en) Treated material
GB0315857D0 (en) Treated material

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120123